Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 6, 2018.
Article Versions
- previous version (July 20, 2018 - 14:19).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2018
Author Information
- 1Virology Department, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, Langen 63225, Germany; and
- 2Shire, 300 Shire Way, Lexington, MA 02421, USA
- ↵* Corresponding Author: Virology Department, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, Langen 63225, Germany; e-mail: Johannes.Bluemel{at}pei.de
Cited By...
Jump to section
- Article
- Abstract
- Background
- Evaluation of Performance Attributes Supporting Maintained Viral Clearance By Chromatography Columns At End of Lifetime
- John Mattila, Regeneron
- Review of Viral Clearance Capacity of Used Chromatography Resins In Biologics Purification Processes
- Glen Bolton, Amgen
- Evaluation of Virus Carryover and Lifetime In Non-platform Process
- Shohei Kobayashi, Chugai Pharmaceutical Co., LTD
- Virus Clearance By Chromatograph: Resin Lifetime and Carryover Studies
- Dayue Chen, Lilly
- Retrospective Evaluation of Cycled Resin In Viral Clearance Studies—a Multiple Company Collaboration
- John Mattila, Regeneron Pharmaceuticals Inc.; Mike Clark, AbbVie Inc.; Justin Weaver and Jeremy Pike, Alexion; Bradford Stanley, Biogen; Deqiang Yu, Bristol-Myers Squibb; Eileen Wilson and Olga Galperina, GlaxoSmithKline plc; Xinfang Li, ImmunoGen Inc. (now of MabPlex); David Roush and Scott Tobler, Merck, Sharp and Dohme, Inc.; Sherrie Curtis, Roche; Andreas Flicker and Johanna Kindermann, Shire plc; Norbert Schuelke, Takeda; Richard Whitcombe, UCB
- Summary
- Conflict of Interest Declaration
- Reference
- Figures & Data
- References
- Info & Metrics